Takeda Appoints U.S. President

Ramona Sequeira has been named president of Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) Business Unit. Ms. Sequeira will lead all business operations for the U.S., and will report to Christophe Weber, president and chief executive officer of Takeda.
 
Ms. Sequeira has extensive leadership experience across multiple therapy areas including neuroscience, specialty and primary care, and several regions including the U.S., Canada and UK. Most recently she was as vice president, Lilly USA at Eli Lilly and Co. Previously, she was the general manager of Lilly’s UK Hub.
 
“The U.S. is a critical market for Takeda’s future growth, and I am confident that with her strong commercial experience and knowledge of the U.S. healthcare environment, Ramona is the right person to lead this important business unit and play a key role on my leadership team,” said Mr. Weber. “Her more than 20 years of leadership experience and track record of success across multiple healthcare markets, as well as her demonstrated passion for patient centricity, will serve as a critical foundation during Takeda’s global transformation.”